Nicolas Cuttriss, MD, MPH, FAAP
ECHO Diabetes COVID-19 Director
Latest information on COVID-19
Last updated: June 1, 2020 | 10:47 PM PST
The goal of the Diabetes in the Time of COVID-19 ECHO is to empower primary care providers to address the needs of patients with type 1 and type 2 diabetes in their communities who do not have access to routine specialty care. Preliminary data on outcomes for those with diabetes and COVID-19 indicate higher hospitalization, intensive care, and fatality rates compared to those without reported underlying health conditions. Minimizing hyperglycemia and “poor control” is paramount to reducing diabetes patient risk and vulnerability to infection and complications, including COVID-19.
Now, more than ever, it is important for care teams in the primary care setting to support patients with diabetes to obtain achievable goals for their blood glucose, blood pressure and beyond. Our ECHO program will support you in managing patients with diabetes during and after the COVID-19 pandemic.
This is a series of 16 free, CME (Continuing Medical Education) accredited webinars. You are invited to join us weekly or drop in on any of our sessions. Webinars are held every Wednesday at 9:00am -10:15am PT starting on May 20th, 2020. Our renowned multidisciplinary diabetes faculty from Stanford and more than 10 organizations across the US will address the urgent needs of patients with type 1 and type 2 diabetes who require complex management in the primary care setting.
course topics are subject to change
During this time of global crisis, the Project ECHO model has a special role to play in quickly helping to connect experts and frontline healthcare professionals caring for patients with diabetes during the time of COVID-19.